Efficacy of lithium treatment in Kleine-Levin syndrome

F. Muratori, N. Bertini, G. Masi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The Kleine-Levin syndrome (KLS) is characterized by periodic, sudden-onset episodes of hypersomnia, compulsive hyperphagia, and behavioral-emotional symptoms, lasting from a few days to a few weeks, with complete remission in the intercritical periods. We report on efficacy of lithium treatment in a highly recurring form of the disorder in a 17-year-old male adolescent. The decreasing severity of the disorder paralleled the progressive increase of lithium dosage, up to 0.9 mEq I-1. Implications regarding the pharmacological treatment of this neglected disorder are discussed.

Original languageEnglish
Pages (from-to)232-233
Number of pages2
JournalEuropean Psychiatry
Volume17
Issue number4
DOIs
Publication statusPublished - Jul 2002

Fingerprint

Kleine-Levin Syndrome
Lithium
Disorders of Excessive Somnolence
Hyperphagia
Behavioral Symptoms
Pharmacology
Therapeutics

Keywords

  • Adolescence
  • Kleine-Levin syndrome
  • Lithium

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Efficacy of lithium treatment in Kleine-Levin syndrome. / Muratori, F.; Bertini, N.; Masi, G.

In: European Psychiatry, Vol. 17, No. 4, 07.2002, p. 232-233.

Research output: Contribution to journalArticle

@article{ac8cea0249684c0cb80ddeb30b475844,
title = "Efficacy of lithium treatment in Kleine-Levin syndrome",
abstract = "The Kleine-Levin syndrome (KLS) is characterized by periodic, sudden-onset episodes of hypersomnia, compulsive hyperphagia, and behavioral-emotional symptoms, lasting from a few days to a few weeks, with complete remission in the intercritical periods. We report on efficacy of lithium treatment in a highly recurring form of the disorder in a 17-year-old male adolescent. The decreasing severity of the disorder paralleled the progressive increase of lithium dosage, up to 0.9 mEq I-1. Implications regarding the pharmacological treatment of this neglected disorder are discussed.",
keywords = "Adolescence, Kleine-Levin syndrome, Lithium",
author = "F. Muratori and N. Bertini and G. Masi",
year = "2002",
month = "7",
doi = "10.1016/S0924-9338(02)00661-2",
language = "English",
volume = "17",
pages = "232--233",
journal = "Psychiatrie et Psychobiologie",
issn = "0924-9338",
publisher = "Psychiatrie & psychobiologie",
number = "4",

}

TY - JOUR

T1 - Efficacy of lithium treatment in Kleine-Levin syndrome

AU - Muratori, F.

AU - Bertini, N.

AU - Masi, G.

PY - 2002/7

Y1 - 2002/7

N2 - The Kleine-Levin syndrome (KLS) is characterized by periodic, sudden-onset episodes of hypersomnia, compulsive hyperphagia, and behavioral-emotional symptoms, lasting from a few days to a few weeks, with complete remission in the intercritical periods. We report on efficacy of lithium treatment in a highly recurring form of the disorder in a 17-year-old male adolescent. The decreasing severity of the disorder paralleled the progressive increase of lithium dosage, up to 0.9 mEq I-1. Implications regarding the pharmacological treatment of this neglected disorder are discussed.

AB - The Kleine-Levin syndrome (KLS) is characterized by periodic, sudden-onset episodes of hypersomnia, compulsive hyperphagia, and behavioral-emotional symptoms, lasting from a few days to a few weeks, with complete remission in the intercritical periods. We report on efficacy of lithium treatment in a highly recurring form of the disorder in a 17-year-old male adolescent. The decreasing severity of the disorder paralleled the progressive increase of lithium dosage, up to 0.9 mEq I-1. Implications regarding the pharmacological treatment of this neglected disorder are discussed.

KW - Adolescence

KW - Kleine-Levin syndrome

KW - Lithium

UR - http://www.scopus.com/inward/record.url?scp=0036652436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036652436&partnerID=8YFLogxK

U2 - 10.1016/S0924-9338(02)00661-2

DO - 10.1016/S0924-9338(02)00661-2

M3 - Article

C2 - 12231271

AN - SCOPUS:0036652436

VL - 17

SP - 232

EP - 233

JO - Psychiatrie et Psychobiologie

JF - Psychiatrie et Psychobiologie

SN - 0924-9338

IS - 4

ER -